SEC Filings
Press Releases
November 30, 2005 Health Discovery Corporation Applies for US and Foreign Patent Protection of Prostate Disease Biomarkers Identified Using SVM Technology
November 28, 2005 Health Discovery Corporation Announces Significant Expansion of its Intellectual Property Portfolio
November 22, 2005 Clarient, Inc. & Health Discovery Corporation Jointly Announce Licensing Agreement
November 16, 2005 Health Discovery Corporation Announces Sale of Biomarker Signature for AIDS
November 15, 2005 Health Discovery Corporation Reaffirms Validation Strategy for Its Prostate Biomarkers
October 25, 2005 Health Discovery Corporation Announces Addition to its Board of Directors
September 20, 2005 Health Discovery Corporation Announces New Patent Issuance: Issued Patent Covers Support Vector Machine Pre-Processing Methods
July 14, 2005 Health Discovery Corporation Announces Approval and Issuance of Multiple Patent Applications Covering SVM Methods
May 24, 2005 Health Discovery Corporation in Discussions to License Prostate Cancer Biomarkers
May 16, 2005 Health Discovery Corporation Completes Acquisition of Valuable Support Vector Machine (SVM) Patent Portfolio and Immediately Initiates Licensing and Product Development Program
April 26, 2005 Health Discovery Corporation Announces Issuance of New U.S. Patent Covering Use of SVMs for Processing Multiple Data Sets
April 18, 2005 Health Discovery Corporation Presents Revolutionary New Prostate Cancer Biomarker Discovery at the Molecular Medicine Tri-Conference 2005 in San Francisco
April 12, 2005 Stephen D. Barnhill, M.D., Chairman and CEO of Health Discovery Corporation, to Present "The Biomarker Gold Rush Is On!" at the Third Annual Collaborations and Licensing in the Pharma and Biotech Industries Conference in London, England
April 7, 2005 Stephen D. Barnhill, M.D., Chairman and CEO of Health Discovery Corporation, to Present "New Validated Biomarker Discovery for Prostate Cancer and BPH" at Biomarkers Europe 2005 in London, England
April 4, 2005 Health Discovery Corporation Announces Filing of Patent Application Covering Methods for Enhancing Accuracy of Biomarker Discovery
March 28, 2005 Health Discovery Corporation Announces Approval of Patent Application Covering Fractal Genomics Modeling (FGM) Technology
March 9, 2005 Health Discovery Corporation Announces Completion of Private Placement in Excess of $2.5 Million
March 1, 2005 Health Discovery Corporation Announces Approval of Patent Application Covering Recursive Feature Elimination (RFE) in Support Vector Machines (SVM's)
February 23, 2005 Health Discovery Corporation Introduces New Cellular Imaging Technology to Identify Circulating Tumor Cells in the Blood at the Drug Discovery and Technology Leaders Summit
January 18, 2005 Health Discovery Corporation Announces Approval of Patent Application Covering Feature Selection in Support Vector Machines
January 10, 2005 Health Discovery Corporation returns to "Compliant" status with NASDAQ
